应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
LQDA Liquidia Technologies Inc
休市中 08-21 16:00:00 EDT
68.62
-2.43
-3.42%
盘后
68.80
+0.18
+0.26%
19:51 EDT
最高
71.13
最低
68.05
成交量
170.09万
今开
70.91
昨收
71.05
日振幅
4.33%
总市值
61.42亿
流通市值
48.59亿
总股本
8,951万
成交额
1.17亿
换手率
2.40%
流通股本
7,082万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
异动解读|Liquidia Technologies盘中下跌5.1%,Q2每股收益不及预期延续获利回吐
行情直击 · 08-18
异动解读|Liquidia Technologies盘中下跌5.1%,Q2每股收益不及预期延续获利回吐
异动解读|Liquidia Technologies盘中上涨5.18%,Q2营收大幅超预期下连跌后反弹
行情直击 · 08-14
异动解读|Liquidia Technologies盘中上涨5.18%,Q2营收大幅超预期下连跌后反弹
异动解读|Liquidia Technologies盘中下跌5.06%,Q2每股收益不及预期延续获利回吐压力
行情直击 · 08-14
异动解读|Liquidia Technologies盘中下跌5.06%,Q2每股收益不及预期延续获利回吐压力
异动解读 | Liquidia Technologies盘中大跌5.81%,Q2每股收益不及预期引发获利回吐
异动解读 · 08-13
异动解读 | Liquidia Technologies盘中大跌5.81%,Q2每股收益不及预期引发获利回吐
异动解读|Liquidia Technologies盘中下跌5.12%,Q2业绩高增但EPS未达部分机构预期
行情直击 · 08-13
异动解读|Liquidia Technologies盘中下跌5.12%,Q2业绩高增但EPS未达部分机构预期
财报前瞻 |Liquidia Technologies Inc本季度营收预计增40.67%,机构观点偏正面
财报Agent · 08-05
财报前瞻 |Liquidia Technologies Inc本季度营收预计增40.67%,机构观点偏正面
异动解读|Liquidia Technologies盘中上涨5.41%,报88.475美元
行情直击 · 08-05
异动解读|Liquidia Technologies盘中上涨5.41%,报88.475美元
异动解读|Liquidia Technologies盘前上涨5.57%,报90.00美元
行情直击 · 07-27
异动解读|Liquidia Technologies盘前上涨5.57%,报90.00美元
异动解读|Liquidia盘中上涨6.8%,报86.25美元
行情直击 · 07-22
异动解读|Liquidia盘中上涨6.8%,报86.25美元
异动解读|Liquidia盘中上涨5.05%,报79.07美元
行情直击 · 07-18
异动解读|Liquidia盘中上涨5.05%,报79.07美元
异动解读|Liquidia盘中上涨5.21%,报74.92美元
行情直击 · 07-14
异动解读|Liquidia盘中上涨5.21%,报74.92美元
异动解读|Liquidia盘中下跌8.52%,投行下调评级与董事密集减持持续承压
行情直击 · 07-14
异动解读|Liquidia盘中下跌8.52%,投行下调评级与董事密集减持持续承压
异动解读|Liquidia盘中下跌5.66%,投行下调评级叠加董事密集减持承压
行情直击 · 07-10
异动解读|Liquidia盘中下跌5.66%,投行下调评级叠加董事密集减持承压
异动解读|Liquidia Technologies盘中上涨5.07%,评级下调超跌后反弹逼近目标价
行情直击 · 07-01
异动解读|Liquidia Technologies盘中上涨5.07%,评级下调超跌后反弹逼近目标价
异动解读|Liquidia Technologies盘中下跌5.37%,美银证券下调评级至中性
行情直击 · 06-29
异动解读|Liquidia Technologies盘中下跌5.37%,美银证券下调评级至中性
异动解读|Liquidia Technologies盘前上涨5.96%,YUTREPIA商业化势头强劲叠加学术会议催化
行情直击 · 06-29
异动解读|Liquidia Technologies盘前上涨5.96%,YUTREPIA商业化势头强劲叠加学术会议催化
异动解读|Liquidia Technologies夜盘上涨6.32%,报83.11美元
行情直击 · 06-29
异动解读|Liquidia Technologies夜盘上涨6.32%,报83.11美元
异动解读|Liquidia Technologies盘中上涨5.18%,报74.73美元
行情直击 · 06-23
异动解读|Liquidia Technologies盘中上涨5.18%,报74.73美元
异动解读|Liquidia盘中上涨7.26%,公司宣布在PHA国际肺动脉高压会议上展示研究海报
行情直击 · 06-11
异动解读|Liquidia盘中上涨7.26%,公司宣布在PHA国际肺动脉高压会议上展示研究海报
异动解读|Liquidia盘后上涨5.9%,报63.4美元
行情直击 · 06-06
异动解读|Liquidia盘后上涨5.9%,报63.4美元
加载更多
公司概况
公司名称:
Liquidia Technologies Inc
所属市场:
NASDAQ
上市日期:
--
主营业务:
Liquidia Corporation于2020年6月17日在特拉华州成立。该公司是一家生物制药公司,专注于解决未满足患者需求产品的开发、制造和商业化,目前的重点是肺动脉高压的治疗。该公司通过两家全资子公司Liquidia Technologies和Liquidia PAH作为单一实体运营。该公司通过应用心肺疾病方面的专业知识和专有的PRINT技术进行新产品的研究、开发和制造,PRINT技术是一种粒子工程平台,能够精确生产均匀的药物颗粒,旨在提高广泛疗法的安全性、有效性和性能。通过与第三方的产品开发和研究,该公司拥有将PRINT应用于多种给药途径和药物有效载荷的经验,包括吸入疗法、疫苗、生物制剂、核酸和眼科植入物等。
发行价格:
--
{"stockData":{"symbol":"LQDA","market":"US","secType":"STK","nameCN":"Liquidia Technologies Inc","latestPrice":68.62,"timestamp":1787342400000,"preClose":71.05,"halted":0,"volume":1700916,"hourTrading":{"tag":"盘后","latestPrice":68.8,"preClose":68.62,"latestTime":"19:51 EDT","volume":81527,"amount":5595777.8415,"timestamp":1787356269911,"change":0.18,"changeRate":0.002623,"amplitude":0.004668},"delay":0,"changeRate":-0.03420126671358188,"floatShares":70817114,"shares":89508891,"eps":1.4,"marketStatus":"休市中","change":-2.43,"latestTime":"08-21 16:00:00 EDT","open":70.91,"high":71.1255,"low":68.0501,"amount":117498205.70291999,"amplitude":0.043285,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":1.4,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1787558400000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1532577600000,"exchange":"NASDAQ","adjPreClose":71.05,"preHourTrading":{"tag":"盘前","latestPrice":71,"preClose":71.05,"latestTime":"09:29 EDT","volume":1181,"amount":84554.209916,"timestamp":1787318969003,"change":-0.05,"changeRate":-0.000704,"amplitude":0.020408},"postHourTrading":{"tag":"盘后","latestPrice":68.8,"preClose":68.62,"latestTime":"19:51 EDT","volume":81527,"amount":5595777.8415,"timestamp":1787356269911,"change":0.18,"changeRate":0.002623,"amplitude":0.004668},"volumeRatio":1.0338895460612232,"impliedVol":1.1231,"impliedVolPercentile":0.3307},"requestUrl":"/m/hq/s/LQDA","defaultTab":"news","newsList":[{"id":"1184500619","title":"异动解读|Liquidia Technologies盘中下跌5.1%,Q2每股收益不及预期延续获利回吐","url":"https://stock-news.laohu8.com/highlight/detail?id=1184500619","media":"行情直击","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1184500619?lang=zh_cn&edition=full","pubTime":"2026-08-18 23:03","pubTimestamp":1787065409,"startTime":"0","endTime":"0","summary":"8月18日,Liquidia Technologies盘中下跌5.1%,报73.74美元/股,成交额1996.73万美元,延续财报发布后的回调走势。消息面上,公司于8月12日发布Q2财报,每股收益0.74美元,低于FactSet预期的0.76美元;营收1.717亿美元,同比大幅增长,超出市场预期的1.685亿美元。核心产品YUTREPIA净销售额约1.704亿美元,环比增长31%,独立患者处方数约5,900人。尽管营收端持续放量,但EPS未达部分机构预期,叠加公司股价年内涨幅已超一倍,市场获利回吐情绪持续释放。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LQDA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1197326088","title":"异动解读|Liquidia Technologies盘中上涨5.18%,Q2营收大幅超预期下连跌后反弹","url":"https://stock-news.laohu8.com/highlight/detail?id=1197326088","media":"行情直击","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1197326088?lang=zh_cn&edition=full","pubTime":"2026-08-14 23:03","pubTimestamp":1786719801,"startTime":"0","endTime":"0","summary":"8月14日,Liquidia Technologies盘中上涨5.18%,报75.84美元/股,成交额5809.96万美元。消息面上,公司于8月12日发布Q2财报,营收1.717亿美元同比增长约18.5倍,核心产品YUTREPIA净销售额约1.704亿美元,环比增长31%,独立患者处方数约5,900人,营收超出市场预期的1.685亿美元;但每股收益0.74美元略低于FactSet预期的0.76美元。此前因EPS未达预期叠加年内涨幅已超一倍,股价在前两个交易日累计回调超10%。美银证券此前将公司评级下调至\"中性\",目标价79美元,当前股价仍低于该目标价水平。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LQDA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1193199356","title":"异动解读|Liquidia Technologies盘中下跌5.06%,Q2每股收益不及预期延续获利回吐压力","url":"https://stock-news.laohu8.com/highlight/detail?id=1193199356","media":"行情直击","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1193199356?lang=zh_cn&edition=full","pubTime":"2026-08-14 01:14","pubTimestamp":1786641293,"startTime":"0","endTime":"0","summary":"8月14日,Liquidia Technologies盘中下跌5.06%,报74.8美元/股,成交额1.46亿美元,延续前一交易日跌势。消息面上,公司于8月12日盘前发布第二季度财报,Q2每股收益为0.74美元,低于FactSet预期的0.76美元;营收1.717亿美元,同比增长约18.5倍,核心产品YUTREPIA净销售额约1.704亿美元,环比增长31%,独立患者处方数约5,900人,营收超出市场一致预期的1.685亿美元。尽管营收端表现亮眼,但EPS未达部分机构预期,叠加此前公司股价年内涨幅已超一倍,市场获利回吐情绪浓厚。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LQDA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1146449266","title":"异动解读 | Liquidia Technologies盘中大跌5.81%,Q2每股收益不及预期引发获利回吐","url":"https://stock-news.laohu8.com/highlight/detail?id=1146449266","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1146449266?lang=zh_cn&edition=full","pubTime":"2026-08-13 00:40","pubTimestamp":1786552857,"startTime":"0","endTime":"0","summary":"Liquidia Technologies Inc(LQDA)今日盘中大幅下挫5.81%,引发市场广泛关注。消息面上,公司于盘前发布第二季度财报。尽管营收同比增长约18.5倍至17.17亿美元,核心产品YUTREPIA净销售额达17.04亿美元,均超出市场预期,但每股收益为0.74美元,低于FactSet预期的0.76美元及LSEG汇总的0.7722美元预期。净利润亦未达部分分析师预测。此前公司股价年内涨幅已超过一倍,市场已充分消化高增长预期。在EPS不及预期的情况下,投资者选择获利了结。此外,美银证券此前已将公司评级从“买入”下调至“中性”,目标价定为79美元,这对市场情绪形成进一步压制。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["LQDA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1165651871","title":"异动解读|Liquidia Technologies盘中下跌5.12%,Q2业绩高增但EPS未达部分机构预期","url":"https://stock-news.laohu8.com/highlight/detail?id=1165651871","media":"行情直击","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1165651871?lang=zh_cn&edition=full","pubTime":"2026-08-13 00:35","pubTimestamp":1786552525,"startTime":"0","endTime":"0","summary":"8月13日,Liquidia Technologies盘中下跌5.12%,报83.545美元/股,成交额1.39亿美元。消息面上,公司于8月12日盘前发布第二季度财报,Q2实现每股收益0.74美元,较去年同期亏损0.49美元大幅扭亏;营收1.717亿美元,同比增长约18.5倍,核心产品YUTREPIA净销售额约1.704亿美元,环比增长31%,独立患者处方数约5,900人。尽管营收超出市场一致预期的1.685亿美元,但EPS未达FactSet预期的0.76美元,叠加此前股价已充分反映高增长预期,市场出现获利回吐。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LQDA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1150680357","title":"财报前瞻 |Liquidia Technologies Inc本季度营收预计增40.67%,机构观点偏正面","url":"https://stock-news.laohu8.com/highlight/detail?id=1150680357","media":"财报Agent","labels":["earningPreview"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1150680357?lang=zh_cn&edition=full","pubTime":"2026-08-05 08:24","pubTimestamp":1785889445,"startTime":"0","endTime":"0","summary":"Liquidia Technologies Inc将于2026年08月12日发布最新季度财报,围绕新一代吸入式治疗产品的放量与商业化推进成为市场关注重点。市场一致预期本季度Liquidia Technologies Inc营收为1.69亿美元,同比增40.67%;预计调整后每股收益为0.74美元,同比增272.32%;预计息税前利润为7,428.59万美元,同比增303.08%。上季度Liquidia Technologies Inc实现营收1.33亿美元,同比增41.58%;毛利率91.08%;归属于母公司股东的净利润为5,286.20万美元,净利率39.79%,调整后每股收益0.52美元,同比增115.56%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"财报前瞻 |Liquidia Technologies Inc本季度营收预计增40.67%,机构观点偏正面","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LQDA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1149333279","title":"异动解读|Liquidia Technologies盘中上涨5.41%,报88.475美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1149333279","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1149333279?lang=zh_cn&edition=full","pubTime":"2026-08-05 00:17","pubTimestamp":1785860274,"startTime":"0","endTime":"0","summary":"8月5日,Liquidia Technologies盘中上涨5.41%,报88.475美元/股,成交额3513.56万美元。Liquidia Technologies所在的制药行业中,个股中,礼来涨0.49%,辉瑞涨2.18%,阿斯利康跌0.16%,强生跌0.76%,默沙东涨0.74%。Liquidia Corporation是一家生物制药公司,专注于解决未满足患者需求产品的开发、制造和商业化,目前的重点是肺动脉高压的治疗。其核心产品YUTREPIA一季度净产品销售额约1.3亿美元,当季EPS为0.52美元,公司下一次财报预计于8月12日发布,市场预期EPS为0.70美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LQDA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1127961968","title":"异动解读|Liquidia Technologies盘前上涨5.57%,报90.00美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1127961968","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1127961968?lang=zh_cn&edition=full","pubTime":"2026-07-27 19:01","pubTimestamp":1785150085,"startTime":"0","endTime":"0","summary":"7月27日,Liquidia Technologies盘前上涨5.57%,报90.00美元/股,成交额16.06万美元。Liquidia Technologies所在的制药行业中,个股中,礼来涨0.25%,强生涨0%,默沙东跌0.28%,施贵宝涨0.34%,辉瑞涨0.08%。Liquidia Corporation是一家生物制药公司,专注于解决未满足患者需求产品的开发、制造和商业化,目前的重点是肺动脉高压的治疗。(以上内容均基于市场公开消息,由程序或算法智能生成,仅作为股价异动提醒,不作为投资建议或交易依据。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LQDA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1181056163","title":"异动解读|Liquidia盘中上涨6.8%,报86.25美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1181056163","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1181056163?lang=zh_cn&edition=full","pubTime":"2026-07-22 23:39","pubTimestamp":1784734753,"startTime":"0","endTime":"0","summary":"7月22日,Liquidia盘中上涨6.8%,报86.25美元/股,成交额5282.27万美元。Liquidia所在的制药行业中,个股中,礼来跌0.8%,强生涨1.96%,默沙东涨1.83%,辉瑞涨0.48%,诺和诺德跌1.27%。Liquidia Corporation是一家生物制药公司,专注于解决未满足患者需求产品的开发、制造和商业化,目前的重点是肺动脉高压的治疗。该公司通过应用心肺疾病方面的专业知识和专有的PRINT技术进行新产品的研究、开发和制造。(以上内容均基于市场公开消息,由程序或算法智能生成,仅作为股价异动提醒,不作为投资建议或交易依据。)","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LQDA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1184282530","title":"异动解读|Liquidia盘中上涨5.05%,报79.07美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1184282530","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1184282530?lang=zh_cn&edition=full","pubTime":"2026-07-18 01:03","pubTimestamp":1784307828,"startTime":"0","endTime":"0","summary":"7月18日,Liquidia盘中上涨5.05%,报79.07美元/股,成交额4194.29万美元。Liquidia所在的制药行业中,整体表现偏强,个股中,礼来涨0.84%,强生涨1.23%,默沙东涨0.25%,辉瑞跌0.12%,施贵宝涨0.83%。(以上内容均基于市场公开消息,由程序或算法智能生成,仅作为股价异动提醒,不作为投资建议或交易依据。)","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LQDA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1130088418","title":"异动解读|Liquidia盘中上涨5.21%,报74.92美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1130088418","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1130088418?lang=zh_cn&edition=full","pubTime":"2026-07-14 23:40","pubTimestamp":1784043603,"startTime":"0","endTime":"0","summary":"7月14日,Liquidia盘中上涨5.21%,报74.92美元/股,成交额2232.96万美元。Liquidia所在的制药行业中,整体表现偏弱,个股中,礼来跌2.46%,强生跌1.78%,辉瑞跌1.16%,默沙东跌2.38%,阿斯利康跌2.13%。(以上内容均基于市场公开消息,由程序或算法智能生成,仅作为股价异动提醒,不作为投资建议或交易依据。)","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LQDA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1106432202","title":"异动解读|Liquidia盘中下跌8.52%,投行下调评级与董事密集减持持续承压","url":"https://stock-news.laohu8.com/highlight/detail?id=1106432202","media":"行情直击","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1106432202?lang=zh_cn&edition=full","pubTime":"2026-07-14 00:15","pubTimestamp":1783959358,"startTime":"0","endTime":"0","summary":"7月14日,Liquidia盘中下跌8.52%,报71.19美元/股,成交额7567.27万美元。消息面上,美银证券此前将Liquidia评级从\"买入\"下调至\"中性\",目标价79美元。与此同时,公司董事Bloch Stephen M自6月至7月初累计卖出超30万股,套现金额超2200万美元,频繁的内部人减持进一步加剧市场抛压。当前股价已大幅跌破美银目标价,较7月10日收盘价77.93美元继续下行,显示评级下调与高管减持的负面效应仍在发酵,市场情绪持续偏弱。(以上内容均基于市场公开消息,由程序或算法智能生成,仅作为股价异动提醒,不作为投资建议或交易依据。)","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LQDA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1170534184","title":"异动解读|Liquidia盘中下跌5.66%,投行下调评级叠加董事密集减持承压","url":"https://stock-news.laohu8.com/highlight/detail?id=1170534184","media":"行情直击","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1170534184?lang=zh_cn&edition=full","pubTime":"2026-07-10 22:21","pubTimestamp":1783693317,"startTime":"0","endTime":"0","summary":"7月10日,Liquidia盘中下跌5.66%,报76.84美元/股,成交额2070.57万美元。消息面上,美银证券此前将Liquidia评级从\"买入\"下调至\"中性\",目标价79美元。与此同时,公司董事Bloch Stephen M近期持续大规模减持,仅6月至7月初累计卖出超30万股,套现金额超2200万美元,频繁的内部人减持进一步加剧市场抛压。当前股价已跌破美银目标价,显示市场情绪偏弱。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LQDA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1117263612","title":"异动解读|Liquidia Technologies盘中上涨5.07%,评级下调超跌后反弹逼近目标价","url":"https://stock-news.laohu8.com/highlight/detail?id=1117263612","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1117263612?lang=zh_cn&edition=full","pubTime":"2026-07-01 00:21","pubTimestamp":1782836516,"startTime":"0","endTime":"0","summary":"6月30日,Liquidia Technologies盘中上涨5.07%,报78.93美元/股,成交额3370.43万美元。消息面上,此前一交易日美银证券将公司评级从\"买入\"下调至\"中性\",目标价设定为79美元,引发获利回吐导致股价一度跌逾5%至73美元附近。当前股价反弹至接近目标价水平,显示市场消化评级调整后的估值修复。基本面方面,公司一季度EPS 0.52美元,超预期的0.41美元,核心产品YUTREPIA净产品销售额约1.3亿美元,同比扭亏为盈,独立患者处方超4500份。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LQDA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1138967241","title":"异动解读|Liquidia Technologies盘中下跌5.37%,美银证券下调评级至中性","url":"https://stock-news.laohu8.com/highlight/detail?id=1138967241","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1138967241?lang=zh_cn&edition=full","pubTime":"2026-06-29 22:09","pubTimestamp":1782742182,"startTime":"0","endTime":"0","summary":"6月29日,Liquidia Technologies盘中下跌5.37%,报73.01美元/股,成交额3070.31万美元。消息面上,美银证券将Liquidia评级从\"买入\"下调至\"中性\",目标价设定为79美元。此前该股因YUTREPIA商业化放量及学术会议催化一度在盘前走高,但评级下调引发获利回吐压力。一季度公司实现EPS 0.52美元,超市场预期的0.41美元,净产品销售额约1.3亿美元,同比扭亏为盈。尽管基本面强劲,投行下调评级或暗示当前估值已充分反映利好,短期上行空间受限。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LQDA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1128215928","title":"异动解读|Liquidia Technologies盘前上涨5.96%,YUTREPIA商业化势头强劲叠加学术会议催化","url":"https://stock-news.laohu8.com/highlight/detail?id=1128215928","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1128215928?lang=zh_cn&edition=full","pubTime":"2026-06-29 16:02","pubTimestamp":1782720161,"startTime":"0","endTime":"0","summary":"6月29日,Liquidia Technologies盘前上涨5.96%,报80.97美元/股,成交额5.01万美元。消息面上,公司核心产品YUTREPIA商业化持续放量,一季度净产品销售额约1.3亿美元,超4500份独立患者处方,同比实现扭亏为盈(EPS 0.52美元,远超市场预期的0.41美元)。此外,公司于6月11日宣布将在PHA 2026国际肺动脉高压大会上发布海报数据,学术会议催化叠加业绩高增长预期,持续推升市场情绪。一季度业绩公布后,多家分析师上调目标价。(以上内容均基于市场公开消息,由程序或算法智能生成,仅作为股价异动提醒,不作为投资建议或交易依据。)","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LQDA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1138192096","title":"异动解读|Liquidia Technologies夜盘上涨6.32%,报83.11美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1138192096","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1138192096?lang=zh_cn&edition=full","pubTime":"2026-06-29 14:21","pubTimestamp":1782714114,"startTime":"0","endTime":"0","summary":"6月29日,Liquidia Technologies夜盘上涨6.32%,报83.11美元/股,成交额11.53万美元。Liquidia Technologies所在的制药行业中,个股中,礼来涨1.65%,强生跌0.18%,默沙东跌0.05%,Axsome Therapeutics涨0%,辉瑞涨0%。Liquidia Corporation是一家生物制药公司,专注于解决未满足患者需求产品的开发、制造和商业化,目前重点为肺动脉高压治疗。公司核心产品YUTREPIA已实现商业化,最新季度净产品销售额约1.3亿美元,患者处方数持续增长。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LQDA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1134348790","title":"异动解读|Liquidia Technologies盘中上涨5.18%,报74.73美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1134348790","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1134348790?lang=zh_cn&edition=full","pubTime":"2026-06-23 00:49","pubTimestamp":1782146976,"startTime":"0","endTime":"0","summary":"6月23日,Liquidia Technologies盘中上涨5.18%,报74.73美元/股,成交额7319.12万美元,股价突破此前52周高点73.22美元,创历史新高。Liquidia Technologies所在的制药行业中,个股表现分化,其中Definium Therapeutics涨50.84%,诺和诺德涨7.38%,礼来涨1.29%,强生涨1.21%,辉瑞跌0.42%。Liquidia Corporation是一家生物制药公司,专注于肺动脉高压治疗领域,通过专有的PRINT粒子工程技术平台进行新产品的研发与商业化,该技术能够精确生产均匀的药物颗粒,应用于吸入疗法、疫苗、生物制剂等多种给药途径。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LQDA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1177797738","title":"异动解读|Liquidia盘中上涨7.26%,公司宣布在PHA国际肺动脉高压会议上展示研究海报","url":"https://stock-news.laohu8.com/highlight/detail?id=1177797738","media":"行情直击","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1177797738?lang=zh_cn&edition=full","pubTime":"2026-06-11 22:55","pubTimestamp":1781189706,"startTime":"0","endTime":"0","summary":"消息面上,Liquidia当日宣布将在PHA国际肺动脉高压会议暨科学大会上展示研究海报,显示公司在核心治疗领域的研发进展持续推进。该消息叠加近期股价强势表现——此前一周内公司股价已累计大幅上涨,市场对其肺动脉高压管线的关注度持续升温。Liquidia所在的制药行业当日整体表现积极,辉瑞涨2.79%,礼来涨2.28%,默沙东涨1.53%,强生涨1.0%。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LQDA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1184932935","title":"异动解读|Liquidia盘后上涨5.9%,报63.4美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1184932935","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1184932935?lang=zh_cn&edition=full","pubTime":"2026-06-06 05:17","pubTimestamp":1780694237,"startTime":"0","endTime":"0","summary":"6月6日,Liquidia盘后上涨5.9%,报63.4美元/股,成交额213.32万美元。Liquidia所在的制药行业中,个股中,礼来跌0.93%,强生跌0.33%,默沙东跌0.4%,辉瑞跌0.23%,施贵宝跌0.12%。Liquidia Corporation是一家生物制药公司,专注于肺动脉高压治疗领域,通过专有的PRINT粒子工程技术平台进行药物研发与商业化,该技术能精确生产均匀药物颗粒,应用于吸入疗法、疫苗、生物制剂等多种给药途径。(以上内容均基于市场公开消息,由程序或算法智能生成,仅作为股价异动提醒,不作为投资建议或交易依据。)","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LQDA"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.liquidia.com","stockEarnings":[{"period":"1week","weight":-0.0782},{"period":"1month","weight":-0.2116},{"period":"3month","weight":0.1253},{"period":"6month","weight":1.0429},{"period":"1year","weight":1.5136},{"period":"ytd","weight":0.9896}],"compareEarnings":[{"period":"1week","weight":-0.0137},{"period":"1month","weight":0.0245},{"period":"3month","weight":0.0269},{"period":"6month","weight":0.1107},{"period":"1year","weight":0.2048},{"period":"ytd","weight":0.1229}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Liquidia Corporation于2020年6月17日在特拉华州成立。该公司是一家生物制药公司,专注于解决未满足患者需求产品的开发、制造和商业化,目前的重点是肺动脉高压的治疗。该公司通过两家全资子公司Liquidia Technologies和Liquidia PAH作为单一实体运营。该公司通过应用心肺疾病方面的专业知识和专有的PRINT技术进行新产品的研究、开发和制造,PRINT技术是一种粒子工程平台,能够精确生产均匀的药物颗粒,旨在提高广泛疗法的安全性、有效性和性能。通过与第三方的产品开发和研究,该公司拥有将PRINT应用于多种给药途径和药物有效载荷的经验,包括吸入疗法、疫苗、生物制剂、核酸和眼科植入物等。","yearOnYearQuotes":[{"month":1,"riseRate":0.75,"avgChangeRate":0.081499},{"month":2,"riseRate":0.75,"avgChangeRate":0.042796},{"month":3,"riseRate":0.5,"avgChangeRate":-0.012167},{"month":4,"riseRate":0.375,"avgChangeRate":-0.058158},{"month":5,"riseRate":0.875,"avgChangeRate":0.19539},{"month":6,"riseRate":0.25,"avgChangeRate":-0.029487},{"month":7,"riseRate":0.375,"avgChangeRate":0.004032},{"month":8,"riseRate":0.444444,"avgChangeRate":0.022445},{"month":9,"riseRate":0.375,"avgChangeRate":0.049793},{"month":10,"riseRate":0.625,"avgChangeRate":0.025896},{"month":11,"riseRate":0.75,"avgChangeRate":0.074904},{"month":12,"riseRate":0.75,"avgChangeRate":0.150821}],"exchange":"NASDAQ","name":"Liquidia Technologies Inc","nameEN":"Liquidia Technologies Inc"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Liquidia Technologies Inc(LQDA)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Liquidia Technologies Inc(LQDA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Liquidia Technologies Inc,LQDA,Liquidia Technologies Inc股票,Liquidia Technologies Inc股票老虎,Liquidia Technologies Inc股票老虎国际,Liquidia Technologies Inc行情,Liquidia Technologies Inc股票行情,Liquidia Technologies Inc股价,Liquidia Technologies Inc股市,Liquidia Technologies Inc股票价格,Liquidia Technologies Inc股票交易,Liquidia Technologies Inc股票购买,Liquidia Technologies Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Liquidia Technologies Inc(LQDA)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Liquidia Technologies Inc(LQDA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}